RT Journal Article
SR Electronic
T1 Guidelines on the management of ascites in cirrhosis
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP gutjnl-2020-321790
DO 10.1136/gutjnl-2020-321790
A1 Guruprasad P Aithal
A1 Naaventhan Palaniyappan
A1 Louise China
A1 Suvi Härmälä
A1 Lucia Macken
A1 Jennifer M Ryan
A1 Emilie A Wilkes
A1 Kevin Moore
A1 Joanna A Leithead
A1 Peter C Hayes
A1 Alastair J O'Brien
A1 Sumita Verma
YR 2020
UL http://gut.bmj.com/content/early/2020/10/15/gutjnl-2020-321790.abstract
AB The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document. The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and management of ascites in patients with cirrhosis. Substantial advances have been made in this area since the publication of the last guideline in 2007. These guidelines are based on a comprehensive literature search and comprise systematic reviews in the key areas, including the diagnostic tests, diuretic use, therapeutic paracentesis, use of albumin, transjugular intrahepatic portosystemic stent shunt, spontaneous bacterial peritonitis and beta-blockers in patients with ascites. Where recent systematic reviews and meta-analysis are available, these have been updated with additional studies. In addition, the results of prospective and retrospective studies, evidence obtained from expert committee reports and, in some instances, reports from case series have been included. Where possible, judgement has been made on the quality of information used to generate the guidelines and the specific recommendations have been made according to the ‘Grading of Recommendations Assessment, Development and Evaluation (GRADE)’ system. These guidelines are intended to inform practising clinicians, and it is expected that these guidelines will be revised in 3 years’ time.